Overview
Jordi Alamillo-Bertran practices practicing medicine in Barcelona, Spain.
Alamillo-Bertran is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and PIK3CA-Related Overgrowth Spectrum.
They are actively involved in clinical research, co-authoring 26 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jordi Alamillo-Bertran
Is Jordi Alamillo-Bertran a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Jordi Alamillo-Bertran is classified as an Distinguished expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jordi Alamillo-Bertran participate in research or clinical trials?
Yes. Jordi Alamillo-Bertran has published 26 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Jordi Alamillo-Bertran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerAlamillo-Bertran isDistinguished. Learn about EGFR Positive Lung Cancer.
- Advanced
- Lung CancerAlamillo-Bertran isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Alamillo-Bertran isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- PIK3CA-Related Overgrowth SpectrumAlamillo-Bertran isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Small Cell Lung Cancer (SCLC)Alamillo-Bertran isExperienced. Learn about Small Cell Lung Cancer (SCLC).